Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | 0.120 | 17 | 50194840 | intron variant | C/T | snv | 7.0E-06 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin and Connective Tissue Diseases; Musculoskeletal Diseases | 0.700 | 1.000 | 7 | 1998 | 2017 | |||||||
|
0.807 | 0.240 | 17 | 50196930 | intron variant | T/A;G | snv |
|
Eye Diseases | 0.040 | 0.500 | 4 | 2007 | 2011 | ||||||||
|
1.000 | 0.040 | 17 | 50202995 | intron variant | G/A;C | snv |
|
Eye Diseases | 0.030 | 0.667 | 3 | 2007 | 2011 | ||||||||
|
0.807 | 0.240 | 17 | 50196930 | intron variant | T/A;G | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.710 | 0.500 | 2 | 2007 | 2011 | ||||||||
|
0.807 | 0.240 | 17 | 50196930 | intron variant | T/A;G | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.710 | 0.500 | 2 | 2007 | 2011 | ||||||||
|
1.000 | 0.040 | 17 | 50203629 | intron variant | A/C | snv | 0.80 |
|
Eye Diseases | 0.010 | 1.000 | 1 | 2007 | 2007 | |||||||
|
1.000 | 0.040 | 17 | 50203295 | intron variant | AA/-;A;AAA | delins | 0.18 |
|
Otorhinolaryngologic Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.763 | 0.320 | 17 | 50200388 | intron variant | C/A | snv | 0.14 |
|
Nervous System Diseases; Wounds and Injuries | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.763 | 0.320 | 17 | 50200388 | intron variant | C/A | snv | 0.14 |
|
Musculoskeletal Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.763 | 0.320 | 17 | 50200388 | intron variant | C/A | snv | 0.14 |
|
Digestive System Diseases | 0.010 | < 0.001 | 1 | 2018 | 2018 | |||||||
|
0.763 | 0.320 | 17 | 50200388 | intron variant | C/A | snv | 0.14 |
|
Pathological Conditions, Signs and Symptoms | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.763 | 0.320 | 17 | 50200388 | intron variant | C/A | snv | 0.14 |
|
Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||||
|
0.763 | 0.320 | 17 | 50200388 | intron variant | C/A | snv | 0.14 |
|
Nutritional and Metabolic Diseases; Musculoskeletal Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.763 | 0.320 | 17 | 50200388 | intron variant | C/A | snv | 0.14 |
|
Musculoskeletal Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.763 | 0.320 | 17 | 50200388 | intron variant | C/A | snv | 0.14 |
|
Pathological Conditions, Signs and Symptoms; Musculoskeletal Diseases; Nervous System Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.763 | 0.320 | 17 | 50200388 | intron variant | C/A | snv | 0.14 |
|
Wounds and Injuries | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.763 | 0.320 | 17 | 50200388 | intron variant | C/A | snv | 0.14 |
|
Musculoskeletal Diseases; Wounds and Injuries | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.763 | 0.320 | 17 | 50200388 | intron variant | C/A | snv | 0.14 |
|
Pathological Conditions, Signs and Symptoms; Digestive System Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.763 | 0.320 | 17 | 50200388 | intron variant | C/A | snv | 0.14 |
|
Pathological Conditions, Signs and Symptoms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.807 | 0.240 | 17 | 50196930 | intron variant | T/A;G | snv |
|
Neoplasms; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2007 | 2007 | ||||||||
|
0.807 | 0.240 | 17 | 50196930 | intron variant | T/A;G | snv |
|
Neoplasms; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2007 | 2007 | ||||||||
|
0.807 | 0.240 | 17 | 50196930 | intron variant | T/A;G | snv |
|
Neoplasms; Stomatognathic Diseases; Otorhinolaryngologic Diseases | 0.700 | 1.000 | 1 | 2010 | 2010 | ||||||||
|
0.882 | 0.040 | 17 | 50189930 | intron variant | G/A;C;T | snv | 0.52; 4.0E-06 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.882 | 0.040 | 17 | 50189930 | intron variant | G/A;C;T | snv | 0.52; 4.0E-06 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.882 | 0.040 | 17 | 50189930 | intron variant | G/A;C;T | snv | 0.52; 4.0E-06 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2014 | 2014 |